FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
0.32 |
IU/g |
0.06 |
0.17 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47497 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
9.92 |
ml/min/g |
0.65 |
1.95 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46726 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
8.48 |
ml/min/g |
0.61 |
1.92 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46942 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
8.3 |
ml/min/g |
0.6 |
1.9 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46943 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
51.91 |
% |
5.07 |
14.35 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46138 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
29.49 |
% |
1.6 |
5.06 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47149 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
|
3.78 |
ml/min/g |
0.3 |
0.74 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44791 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
10.49 |
ml/min/g |
0.22 |
0.71 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46725 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
4.34 |
ml/min/g |
0.54 |
1.52 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46274 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
5 |
post-ischemic value/pre-ischemic value x 100% |
38.74 |
% |
3.13 |
6.99 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47150 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
4.41 |
ml/min/g |
0.22 |
0.69 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46275 |
461 |
FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
18.55 |
IU/g |
1.08 |
3.4 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48903 |
461 |
FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
11.3 |
IU/g |
1.12 |
3.55 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46001 |
461 |
FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
8 |
|
12.22 |
IU/g |
1.74 |
4.93 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46005 |
461 |
FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.35 |
IU/g |
0.06 |
0.2 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47360 |
461 |
FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
0.43 |
IU/g |
0.06 |
0.2 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47356 |
461 |
FHH-Chr 11BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
3.1 |
ml/min/g |
0.18 |
0.58 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44790 |
461 |
FHH-Chr 11BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
55.35 |
% |
4.42 |
13.98 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46139 |
461 |
FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
0.36 |
IU/g |
0.05 |
0.16 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47492 |
461 |
FHH-Chr 11BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
23.38 |
IU/g |
2.68 |
7.59 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48900 |
461 |